Dr Rebekah Bower
Rebekah is a biomedical researcher investigating the molecular mechanisms of prostate cancer metastasis to further drug development efforts in these arenas. Her research includes in vivo mouse models and in vitro characterisation of metastatic cancer cells with the ultimate aim of guiding drug development efforts targeting metastatic cancer cell phenotypes. Rebekah has a background in GPCR receptor pharmacology and peptide chemistry. She is proficient in peptide synthesis and purification methodologies, cell culture techniques and various cell signalling/binding assays. Rebekah also has experience in immunohistochemistry and human tissue handling at the Centre for Brain Research.